Skip to main content
Adocia logo

Adocia — Investor Relations & Filings

Ticker · ADOC ISIN · FR0011184241 LEI · 969500ZL79KYH9PTYP78 PA Real estate activities
Open in API
Filings indexed 826 across all filing types
Latest filing 2015-03-10 Earnings Release
Country FR France
Listing PA ADOC

About Adocia

https://www.adocia.com

Adocia is a clinical-stage biotechnology company that specializes in developing innovative treatments for metabolic diseases, with a primary focus on diabetes and obesity. The company's core expertise is the development of novel formulations of approved peptides, proteins, and metabolic hormones, such as insulin, to improve their therapeutic efficacy. Adocia leverages proprietary technology platforms to create a pipeline of specialty products. Its research also extends to novel cell therapy approaches, including an immunoprotective scaffold for cell delivery. The company's business model involves advancing its product candidates to clinical proof-of-concept before licensing them to partners for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
Communiqués au titre de l'obligation d'information permanente / Communiqué sur comptes, résultats, chiffres d’affaires
Earnings Release Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" and explicitly states: "Adocia annonce aujourd'hui ses résultats financiers annuels pour l'année 2014." It provides key financial highlights (cash position, R&D spend, net loss/profit under IFRS/statutory accounts) and details on clinical development progress and outlook for 2015. This structure—a press release summarizing annual financial performance, often released before the full 10-K or Annual Report—is characteristic of an Earnings Release (ER). It is not the full Annual Report (10-K) nor a comprehensive Interim Report (IR). It also announces a conference call, which is typical for an ER. Since it focuses on the *release* of the annual results summary, ER is the most appropriate classification, rather than RPA (which usually announces the *publication* of a larger document). FY 2014
2015-03-10 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Board/Management Information Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces strategic corporate actions: the creation of a US subsidiary and the hiring of key personnel (Dr. Simon Bruce and Stephen Daly) to manage US business development and investor relations. This type of announcement, focusing on management changes, strategic expansion, and business updates, is characteristic of a general corporate announcement rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed financial report (IR). Since it announces management/director appointments (though focused on business development roles in a new subsidiary, it relates to senior personnel changes) and strategic business moves, it aligns best with Board/Management Information (MANG) or potentially a general Regulatory Filing (RNS) if MANG is too specific. Given the focus on hiring key executives (Dr. Bruce and Mr. Daly) to lead the US expansion, MANG is a strong candidate, but press releases announcing strategic hires and subsidiary creation often fall under general corporate news. However, looking at the definitions, MANG is specifically for 'Announcement of changes in the company's board of directors or senior management.' The hiring of a Medical Director and a Commercial Director for the US subsidiary fits the 'senior management' criteria. Since it is a press release announcing these changes, it is classified as MANG.
2015-03-05 French
Communicated under the obligation to provide permanent information / Other communications
Board/Management Information Classification · 1% confidence The document is explicitly titled '# PRESS RELEASE' and contains announcements regarding business strategy (US subsidiary opening), management appointments (Simon Bruce, Stephen Daly), and pipeline updates. This format is characteristic of an initial, brief announcement of significant corporate news, rather than a comprehensive financial report (like 10-K or IR) or a transcript of a call. Since it is a press release announcing corporate actions and management changes, it most closely aligns with the general category for corporate announcements that aren't strictly financial results or regulatory filings, but given the specific options, it is a general corporate announcement. It is not an Earnings Release (ER) as it doesn't focus on financial results, nor is it a Management Discussion & Analysis (MDA). It is a general corporate update. Since there isn't a specific 'Press Release' code, and it details management changes and strategic moves, it falls under the general regulatory/corporate announcement category. However, the content heavily features management appointments, which points towards MANG, but the primary purpose is a strategic announcement. Given the options, and the nature of the content (strategic move and key personnel appointments), it is best classified as a general corporate announcement. Since 'RNS' is the fallback for miscellaneous regulatory/corporate announcements, and this is a standard press release format, RNS is the most appropriate fit among the provided codes for a non-financial, non-specific corporate update.
2015-03-05 English
Communiqués au titre de l'obligation d'information permanente / Communiqué sur comptes, résultats, chiffres d’affaires
Earnings Release Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" and announces the "chiffre d'affaires et situation nette de trésorerie pour l'année 2014" (revenue and net cash position for the year 2014). It provides key financial highlights for the full year 2014 and Q4 2014, including revenue figures, cash balance, and details on licensing agreements. This format, focusing on key financial metrics immediately following the end of a period (in this case, the fiscal year 2014, announced in February 2015), strongly indicates an Earnings Release (ER). It is not the comprehensive Annual Report (10-K) because it explicitly states that the full annual results will be published later ("Publication des résultats annuels 2014 : mardi 10 mars 2015"). It is too detailed for just a simple announcement of a report (RPA/RNS) but lacks the full scope of a 10-K or a comprehensive Interim Report (IR). Therefore, Earnings Release (ER) is the most appropriate classification. FY 2014
2015-02-17 French
Communicated under the obligation to provide permanent information / Communication relating to accounts, results, and turnover
Earnings Release Classification · 1% confidence The document is titled "ADOCIA: annual revenue and net cash position for 2014" and provides detailed financial figures for the full year 2014, including revenue tables comparing 2014 to 2013, and a cash position as of December 31, 2014. It explicitly announces annual results. Although it is presented as a 'PRESS RELEASE', the content is a comprehensive summary of the full year's financial performance, which aligns most closely with the content of an Earnings Release (ER) or potentially an Interim/Quarterly Report (IR) if it were for a shorter period. Since it covers the *full year* and details revenue and cash position, it functions as the primary announcement of annual results, fitting the definition of an Earnings Release (ER) which covers periodical financial results. It is not the full 10-K, nor is it just a short announcement of a future report (RPA). FY 2014
2015-02-17 English
Share buybacks / Liquidity contracts Information related to liquidity contracts
Capital/Financing Update Classification · 1% confidence The document is a short press release dated February 10, 2015, announcing a 'modification of the means allocated to its liquidity agreement' involving a partial withdrawal of funds from an agreement with Kepler Capital Markets SA. This action relates to the company's share trading/liquidity management. This type of announcement, concerning the company's own shares or capital structure management, fits best under 'Transaction in Own Shares' (POS) or potentially 'Capital/Financing Update' (CAP). Since it specifically details the modification of the liquidity agreement (which involves buying/selling shares to maintain liquidity), POS is the most precise fit. It is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Given the short length and the nature of the announcement, it is not a fallback (RPA/RNS) unless no other category fits perfectly, but POS is a strong match.
2015-02-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.